KMD Bioscience has been dedicated to the research and production of recombinant protein prokaryotic expression for many years. With extensive experience in prokaryotic protein expression as well as industrial-scale protein fermentation and purification, we have accumulated technical expertise from over 400 prokaryotic protein production projects annually. Based on this wealth of experience, KMD has designed an effective protein expression vector system, incorporating various fusion tags (His, GST, SUMO, FLAG, etc.), capable of expressing recombinant proteins with molecular weights exceeding 150kDa in soluble form. Additionally, we have established a collection of diverse expression strains, including low-temperature induced strains (for protein expression at 10-16°C), ensuring the high quality of every recombinant protein production. Clients need only provide us with a protein sequence, CDS, or protein name, and our experienced scientists can quickly develop a comprehensive Protein Expression and Purification Plan, providing clients with high-quality services in a short period of time.
Recombinant protein prokaryotic expression has become increasingly mature after years. However, to achieve high levels of soluble protein expression and high yields in the E. coli expression system, especially for large proteins and certain pharmaceutical proteins, a high-quality expression strategy is essential. Common small molecule (molecular weight < 10 kDa) protein-based drugs, such as Leptin, Liraglutide, and EGF, are typically expressed in the prokaryotic system in the form of affinity tags and fusion proteins, followed by fermentation and purification. The challenge with such proteins is that they are often expressed as inclusion bodies -fusion tags, requiring complicated renaturation processes after expression. KMD has developed mature technology and accumulated rich experience in the renaturation of inclusion bodies-fusion tags.






0